Regulatory Requirements
Regulatory expectations are converging across FDA, EMA, MHRA, and ICH. USDM helps life sciences teams translate 21 CFR Part 11, CSA, Annex 11, UDI/EU MDR, data integrity, privacy/security, and AI oversight into a controlled operating model that is inspection-ready, scalable, and defensible.
Global regulatory pressure
Modern programs have to satisfy more than one rulebook at once. FDA, EMA, MHRA, and ICH expectations now intersect across electronic records, software assurance, data integrity, cybersecurity, and AI-enabled workflows. USDM helps teams build one operating model instead of a stack of disconnected compliance projects.
Electronic records and signatures
Electronic records, e-signatures, access control, audit trails, and documented procedures still sit at the center of regulated digital work. USDM helps map those controls so systems stay trustworthy as platforms, vendors, and release cycles change.
CSA / CSV / lifecycle control
Validation is no longer a one-time paperwork event. USDM helps teams choose the right evidence, match testing to risk, and keep assurance current across cloud releases, configuration changes, and AI-enabled workflows.
Trustworthy data
ALCOA+ data integrity, privacy obligations, access governance, and cybersecurity controls now live in the same conversation. The goal is to keep records accurate, traceable, and usable when regulators, quality teams, or investigators need evidence.
AI and connected workflows
AI guidance is moving from theory to operating expectation. Whether the use case is drafting, decision support, or embedded product capability, leaders need intended use, human oversight, change control, vendor visibility, and traceable evidence.
What USDM does
USDM connects requirements mapping, control design, validation strategy, evidence architecture, and stakeholder alignment so compliance strengthens speed instead of slowing it down. The result is a pathway that lets the organization move without guessing at the regulatory edge cases.
Deep dives
Explore detailed briefs on high-priority regulatory, compliance, and AI topics — each connecting USDM expertise to the specific challenges your organization faces.
Learn how to achieve 21 CFR Part 11 compliance with secure electronic records, audit trails, eSignatures, and validation best practices for life sciences.
Read the briefLearn what Computer Software Assurance (CSA) means for life sciences, how it differs from traditional validation, and how to apply a risk-based FDA-aligned approach.
Read the briefExplore computer system validation services, understand CSV vs CSA, and learn how life sciences companies can modernize validation to improve compliance, speed, and scalability.
Read the briefLearn how to improve EU MDR/IVDR EUDAMED readiness with practical steps for data, registration, governance, and global medical device regulatory alignment.
Read the briefFrequently Asked Questions
Start with intended use, system criticality, data sensitivity, and geography. Then map the relevant controls across Part 11, Annex 11, CSA/CSV, privacy, security, and AI oversight.
CSA shifts the emphasis from documentation volume to evidence of system performance, intended use, critical thinking, and quality outcomes. That makes validation more efficient and better aligned to fast-moving technology environments.
Clear ownership, risk-based controls, current evidence, traceable decisions, and change discipline across the systems that support regulated work.
Talk to a regulatory specialist
USDM consultants work inside GxP environments every day. We help regulated organizations satisfy FDA, EMA, and global regulatory requirements without proportional increases in headcount.